Fig. 3From: ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinomaThe association analysis between ARL9 mRNA expression and colon adenocarcinoma patient clinical characteristics. A Age B Sex C Stage D T stage E N stage F M stageBack to article page